Articles by James Calloway
P3 Health Partners Soars 200% After First Profit, Lifts 2026 Forecast
P3 Health Partners shares surged over 200% to $13 after posting its first quarterly profit and raising its 2026 adjusted EBITDA outlook. Net income reached $3 million, reversing a $44.2 million loss a year earlier.
UBS Maintains Sell on Ambev Despite Record Brazil Beer Volumes
Ambev shares edged down 0.25% after UBS raised its price target but maintained a Sell rating, as record Brazil beer volumes and strong cash flow were offset by rising costs and competitive pressures.
Pfizer Ramps Up India Expansion, Faces Investor Skepticism
Pfizer is expanding into India with cancer, obesity, and vaccine investments, but investors remain cautious. Q1 revenue rose 5% to $14.5 billion, though generic competition looms.
Palantir Faces Shareholder Vote on Human Rights Amid Ukraine AI Deployments
Palantir Technologies faces shareholder proposals for a human rights review and expanded defense disclosure as its AI tools are used in Ukraine. The vote is set for June 3.
Archer Aviation's $8M Stock Issuance Revives Cash Burn Worries
Archer Aviation files to issue $8M in stock to vendors and register 3.27M shares for resale, intensifying cash burn scrutiny after a $217.7M Q1 loss.
Snap CEO Evan Spiegel Summoned to Senate Over Kids' Online Safety
Snap CEO Evan Spiegel has been invited to testify at a Senate hearing on children's online safety, alongside leaders from Meta, Alphabet, and TikTok.
Bradesco Shares Fall on Rising Credit Provisions Despite Profit Growth
Bradesco's New York-listed shares slipped Friday despite a 16.1% profit beat, as a 26.5% surge in loan-loss provisions and broader banking sector strains drove investor caution.
Grab Shares Sink to 52-Week Low Despite Strong Q1 Earnings as Indonesia Regulatory Risk Looms
Grab shares fell to a 52-week low of $3.46 despite strong Q1 results, as Indonesia's new 8% commission cap on ride-hailing raises margin concerns.
Ondas Soars on $390M Revenue Target After Drone Sales Surge
Ondas raised its 2026 revenue target to at least $390 million after Q1 revenue surged to $50.1 million, sending shares up 27%.
Atmos Energy Lifts Guidance, Boosts Dividend After Strong Q2
Atmos Energy lifted its fiscal 2026 earnings outlook to $8.40-$8.50 per share and hiked its quarterly dividend to $1.00, a 14.9% annual increase, driven by robust Q2 results and Texas expansion.
Figma Stock Surges 10.6% Premarket After AI-Driven Revenue Boost
Figma raises 2026 revenue forecast to $1.422-1.428 billion after Q1 revenue jumps 46% to $333.4 million, fueled by AI tool adoption and new credit charges.
HCW Biologics Posts Profit on China Deal, Faces Nasdaq and Pipeline Tests
HCW Biologics posted a $3.47M profit in Q1 2026, driven by a licensing deal with Trimmune Biotech. The company still trades below Nasdaq's $1 minimum and awaits early human data for its lead alopecia drug.